Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?

Pharmacogenetics and genomics - 1 May 2005

Gardiner Sharon J, Begg Evan J

Abstract excerpt

It is widely claimed that pharmacogenetics may form the basis of 'personalized medicine'. We sought to determine the current utilization of pharmacogenetic testing for drug metabolizing enzymes (DMEs). The hypothesis was that these tests were rarely performed clinically. Questionnaires were sent to 629 individuals representing laboratories, hospitals and universities throughout Australia and New Zealand. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Enzymes
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Pharmacogenetics and Drug Metabolism

Share to Pharmacological Effects and Toxicity Studies

Share to Phenotype

Source

Identifiers

PMID: 15864139
DOI: 10.1097/01213011-200505000-00013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?PMID 15864139Read ↗

Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.Semantic proximity Read ↗

Pharmacogenetics: has it reached the clinic?Semantic proximity Read ↗

Genotyping for drug-metabolizing enzymes--does the promise meet the reality?Semantic proximity Read ↗

TPMT and NUDT15 testing for thiopurine therapy: A major tertiary hospital experience and lessons learnedSemantic proximity Read ↗

The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone.Semantic proximity Read ↗

Systematic review of thiopurine methyltransferase genotype and enzymatic testing strategies.Semantic proximity Read ↗

Increasing relevance of pharmacogenetics of drug metabolism in clinical practice.Semantic proximity Read ↗

Is pharmacogenetic CYP2D6 testing useful?Semantic proximity Read ↗

How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial.Semantic proximity Read ↗

Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: a systematic review.Semantic proximity Read ↗

Utility and adoption of CYP2D6 and CYP2C19 genotyping and its translation into psychiatric clinical practice.Semantic proximity Read ↗

Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.